URGN
UroGen Pharma Ltd. Ordinary SharesData: 2026-09-11
Quick Stats
Sep 11, 202653.0
AI Score
HOLD0.76
Volume Ratio
TBA
Next Earnings
16
+ve Days (30d)
14
-ve Days (30d)
URGN Price vs Max Options Open Interest
How to read this: the line is the stock price; the bars show where the most option open interest sits each day. Strikes with heavy open interest often act as magnets or barriers for price ("max pain" zones). Scroll right for the most recent days.
URGN Max Change In Options Open Interest
How to read this: each bar is the option contract whose open interest changed the most yesterday. Green bars = new positions being opened (conviction building at that strike); red bars = positions being closed. Call builds above the current price suggest upside bets; put builds below it suggest hedging or downside bets.
URGN Options - Sort by Max open Interest (near term)
13th September 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
URGN Daily Out of Money Options - Sort by Max open Interest (near term)
13th September 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
URGN Daily In the Money Options - Sort by Max open Interest (near term)
13th September 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
URGN Most Active Options by Volume(near term)
13th September 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
URGN Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Volume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
URGN Stock Summary
Last updated Sep 11, 2026
URGN is currently trading at $42.31, positioned above its 200-day moving average of $28.64, indicating a long-term uptrend. The stock has a 52-week range of $15.86 to $50.81.
Technical Analysis: The 50-day moving average stands at $43.21, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 42.772, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.009, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates URGN at 53.0/100 with a HOLD recommendation.
URGN (UroGen Pharma Ltd. Ordinary Shares) Indicators
Last updated Sep 11, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 42.772 |
| CMF (20) | 0.009 |
| ROC (10) | -7.011 |
| ADX (14) | 19.619 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.101 |
| AROONOSC (14) | -100.0 |
| WILLAMS %R (14) | -87.253 |
| MFI (14) | 29.752 |
URGN Candlestick Patterns
No validated candlestick patterns fired for URGN in the last 10 sessions — that's normal. Only the ~15 patterns with a backtested edge (out of 60 textbook patterns) are tracked here.
UroGen Pharma Ltd. Ordinary Shares is above the 200 Day SMA but below the 50 Day SMA — long-term uptrend intact but under near-term pressure (Mixed).
URGN Moving Averages Analysis
UroGen Pharma Ltd. Ordinary Shares has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Sep 11, 2026
URGN (UroGen Pharma Ltd. Ordinary Shares) Simple Moving Averages
Moving Averages are last updated Sep 11, 2026
| Days | MA |
|---|---|
| 10 | 43.69 |
| 20 | 45.55 |
| 30 | 45.24 |
| 50 | 43.21 |
| 100 | 36.11 |
| 200 | 28.64 |
URGN Fundamental Analysis
| P/E (Forward) | 39.5257 |
| P/E (Trailing) | -- |
| Market Cap ($) | 2.1 billion |
| Earnings/Share ($) | -1.85 |
| Net Profit Margin (%) | -0.5173 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -0.2429 |
| EPS Estimate Next Year ($) | 2.7943 |
| WallStreet Target Price ($) | 60.00 |
| Most Recent Quarter |
UroGen Pharma Ltd is a clinical-stage biotechnology firm specializing in solutions for urothelial and specialty cancers. The company has developed RTGel reverse-thermal hydrogel, a proprietary technology enhancing the therapeutic profiles of existing drugs by enabling sustained release. Their flagship product, Jelmyto (mitomycin) for pyelocalyceal solution, along with investigational candidate UGN-102 (mitomycin) for intravesical solution, targets non-surgical tumor ablation in forms of non-muscle invasive urothelial cancer. Additionally, their immuno-uro-oncology pipeline includes UGN-301 (zalifrelimab), an anti-CTLA-4 antibody, intended for both monotherapy and combination therapy. Revenue is generated from product sales.